How do you pronounce xigris

LLY Closed. Message Font: Serif Sans-Serif. Prev Thread Next Thread. Author: timetogrow. Record the pronunciation of this word in your own voice and play it to listen to how you have pronounced it.

Practice mode x x x. Have you finished your recording? Yes No, I want to continue. Thank you for contributing Congrats! You've got the pronunciation of Xigris right. Keep up. Seems like your pronunciation of Xigris is not correct. You can try again. Original audio Your audio Congrats! Since you have exceeded your time limit, your recording has been stopped.

Can you pronounce this word better or pronounce in different accent or variation? Contribute mode x x x. Best Answer. Study guides. Science 20 cards. Who is known as the first African American scientist. What is Luis Alvarez's cultural background. What was Benjamin Banneker's ethnic background. Which scientist used mathematical knowledge to calculate the exact measurement of the meter.

Genetics 20 cards. What are chromosomes made of. How are mitosis and meiosis similar. What is a gel electrophoresis chamber. In pea plants what are the two alleles for color. Physics 20 cards. Which term explains whether an object's velocity has increased or decreased over time.

Which of these is a characteristic of nonmetals. What is the only factor needed to calculate change in velocity due to acceleration of gravity 9. What term is used to describe splitting a large atomic nucleus into two smaller ones. Q: How do you pronounce xigris? Write your answer The trial excluded patients who were considered to be at a high risk of bleeding e. Pediatric and immunocompromised i. Patients were monitored for 28 days or until expiration for outcomes analysis. The number-needed-to-treat analysis suggested that one life could be saved for every 16 patients treated with drotrecogin alfa.

The lung and abdomen were the most common sites of infection and there were similar treatment effects between both gram-positive infections and gram-negative infections.

During the infusion period, drotrecogin alfa significantly reduced D-dimer and IL-6 levels from baseline. Drotrecogin alfa treatment resulted in a more rapid resolution of cardiovascular and respiratory dysfunction over a seven day period. During the day study period, there was a trend towards more serious bleeding complications in the treatment group compared to placebo, 3. Moreover, bleeding complications were significantly greater during the 96 hour infusion, which occurred 2.

Four fatal bleeding complications occurred during the drotrecogin alfa infusion period compared to only one fatal bleeding complication after the placebo infusion was completed. Since drotrecogin alfa is a potent anticoagulant, the main adverse effect is an increased risk of bleeding. Drotrecogin alfa is contraindicated in patients in which bleeding could be associated with a high risk of death or significant morbidity.

The contraindications are: 1 active internal bleeding, 2 recent within 3 months hemorrhagic stroke, 3 recent within 2 months intra-cranial or intraspinal surgery, or severe head trauma, 4 trauma with an increase of life-threatening bleeding, 5 presence of epidural catheter, 6 intracranial neoplasm or mass lesion or evidence of cerebral herniation.